EN
Honored at YMEF! Kangding Medical's Dual Awards Highlight the Strength of Domestic Orthopedic Devices
Time : 2025-11-28
From November 14 to 16, 2025, the 2nd Yangtze River Delta International Advanced Medical Equipment Fair (YMEF) concluded successfully in Songjiang, Shanghai. With the theme of "Gathering Innovation Power of Medical Devices to Safeguard Great Health", this fair served as a crucial exchange platform for the medical device industry in the Yangtze River Delta and globally, bringing together over 100 renowned domestic and international enterprises and representatives from more than 3,000 medical institutions.
Shanghai Kangding Medical Device Co., Ltd. secured two important honors凭借 its outstanding product innovation capability and industry influence — its Titanium Alloy Locked Intramedullary Nail System was named a Recommended Product in the medical consumables category of the "2025 Yangtze River Delta Excellent Domestic Medical Equipment and Consumables Selection", and the company was also elected as a Member Unit of the International Cooperation Professional Committee under the Shanghai Yangtze River Delta Medical Device Industry Development Promotion Association, emerging as one of the highlights of the fair.
Legacy of Honors: The Innovation Relay at the 2nd YMEF
(The second person from the left is representing Kangding Medical to receive the award)
This marks the second consecutive year that Kangding Medical has won accolades in the authoritative selection of medical devices in the Yangtze River Delta, underscoring the enterprise's sustained innovative advantages in the field of orthopedic devices.
Looking back to December 7-8, 2024, Kangding Medical had already made its mark with innovative strength at the 1st YMEF. Its independently developed Titanium Alloy Locking Plate System and Subtalar Joint Stabilization Screw stood out from 218 products submitted by 103 enterprises, both clinching the title of Recommended Product in the medical consumables category of the "2024 Yangtze River Delta Excellent Domestic Medical Equipment and Consumables Selection".
From winning awards for two products in 2024 to achieving a "double harvest of excellent product and qualification" in 2025, the 2025-recommended Titanium Alloy Locked Intramedullary Nail System has further refined the company's product portfolio in the field of orthopedic trauma treatment. It now covers multiple sub-fields including limb orthopedics, pediatric orthopedics, foot and ankle surgery, and adult trauma, demonstrating comprehensive clinical solution capabilities.
Exhibition Highlights: Full Product Line Showcase Builds Industry Influence
At the YMEF fair, Kangding Medical exhibited a complete range of products, including orthopedic trauma implants, spinal implants, and surgical instruments. Among them, innovative products such as Hydroxyapatite-Coated External Fixation Pins, Ankle Fusion Intramedullary Nails, Adjustable Figure-of-Eight Plates, and Pediatric Femoral/Tibial Interlocking Intramedullary Nails further focused on active, digital, and intelligent orthopedic devices, earning high recognition from attending leaders and experts.
Kangding Medical actively built bridges for industry exchanges, conducting in-depth discussions on cooperation opportunities with domestic and foreign counterparts. Particularly after becoming a Member Unit of the International Cooperation Professional Committee in 2025, the company will participate more deeply in the coordinated development of the Yangtze River Delta medical device industry and contribute to building a world-class industrial cluster.
Innovation Core: Medicine-Engineering Integration Drives High-Quality Development
Behind the honors lies Kangding Medical's unwavering pursuit of innovation. As a National High-Tech Enterprise and Shanghai Specialized, Refined, Distinctive, and Innovative Enterprise, the company has adhered to the tenet of "Caring for Life, Securing Health" since its establishment in 2009, and established a full-chain system covering "R&D, production, sales, and service". It allocates over 10% of its annual revenue to R&D, and has accumulated more than 30 intellectual property certificates through in-depth "industry-university-research-clinic" cooperation, including 7 invention patents. It has also won multiple awards such as the Second Prize of the National Science and Technology Progress Award and the G60 Sci-Tech Innovation-Driven Top 100.
On the manufacturing front, the company has obtained ISO 13485 International Quality Management System Certification, equipped with a Class 100,000 Cleanroom and professional laboratories for mechanics, chemistry, and microbiology, ensuring product quality through automated equipment. In terms of market layout, its products have covered more than 670 Grade A Tertiary Hospitals in 31 provinces and cities nationwide, with a leading market share in the pediatric orthopedics segment. In the international market, the CareFix trademark has been registered in multiple countries, and products are exported to over a dozen countries and regions including Brazil, Egypt, Colombia, Peru, and Indonesia.
Future Outlook: Dual-Wheel Drive Toward the Global Stage
Based on the continuous recognition from the "Yangtze River Delta Excellent Domestic Medical Device and Consumables Selection", Kangding Medical, leveraging its accumulated technical strength and market foundation, has established a global development strategy driven by "technological innovation" and "market expansion" as dual wheels. At the technical level, the company will continue to deepen medicine-engineering integration and accelerate the R&D and translation of active, digital, and intelligent orthopedic devices. At the market level, it will actively expand its global sales network and optimize its international business layout. As a Member Unit of the International Cooperation Professional Committee of the Shanghai Yangtze River Delta Medical Device Industry Development Promotion Association, Kangding Medical will fully utilize platform advantages to conduct in-depth technical exchanges and cooperation with global industry partners, jointly advancing the innovative development of the medical device sector.
